270th ENMC International Workshop: Consensus for SMN2 genetic analysis in SMA patients 10-12 March, 2023, Hoofddorp, the Netherlands

Emanuela Abiusi, Mar Costa-Roger, Enrico Silvio Bertini, Francesco Danilo Tiziano, Eduardo F Tizzano, all participants

Risultato della ricerca: Contributo in rivistaArticolo in rivista

Abstract

The 270th ENMC workshop aimed to develop a common procedure to optimize the reliability of SMN2 gene copy number determination and to reinforce collaborative networks between molecular scientists and clinicians. The workshop involved neuromuscular and clinical experts and representatives of patient advocacy groups and industry. SMN2 copy number is currently one of the main determinants for therapeutic decision in SMA patients: participants discussed the issues that laboratories may encounter in this molecular test and the cruciality of the accurate determination, due the implications as prognostic factor in symptomatic patients and in individuals identified through newborn screening programmes. At the end of the workshop, the attendees defined a set of recommendations divided into four topics: SMA molecular prognosis assessment, newborn screening for SMA, SMN2 copies and treatments, and modifiers and biomarkers. Moreover, the group draw up a series of recommendations for the companies manufacturing laboratory kits, that will help to minimize the risk of errors, regardless of the laboratories' expertise.
Lingua originaleEnglish
pagine (da-a)114-122
Numero di pagine9
RivistaNeuromuscular Disorders
Volumejan
Numero di pubblicazione34
DOI
Stato di pubblicazionePubblicato - 2024

Keywords

  • SMN1
  • SMN2
  • Spinal muscular atrophy

Fingerprint

Entra nei temi di ricerca di '270th ENMC International Workshop: Consensus for SMN2 genetic analysis in SMA patients 10-12 March, 2023, Hoofddorp, the Netherlands'. Insieme formano una fingerprint unica.

Cita questo